147. The Evolution of the Neurohormonal Hypothesis with Dr. Milton Packer: Part 2 – The Secret to Happiness, The “Aha” Moment, & The Birth Of The Neurohormonal Hypothesis

CardioNerds(Amit Goyal,Daniel Ambinder) and Dr. Mark Belkin, (CardioNerds Correspondent) and Dr. Shirlene Obuobi (CardioNerds Ambassador) from University of Chicago are honored to bring to you the Dr. Milton Packer perspective on the evolution of the neurohormonal hypothesis as part of The CardioNerds Heart Success Series. In part 2 Dr. Packer shares his journey as the trailing spouse and tells the story of how the neurohormonal hypothesis was developed.

Check out theCardioNerdsHeart Failure Success Series Pagefor more heart success episodes and content!

This is a non CME episode. Disclosures: Milton Packer reports receiving consulting fees fromAbbvie, Actavis,Amgen, Amarin,AstraZeneca,Boehringer Ingelheim,Bristol Myers Squibb, Casana, CSL Behring,Cytokinetics,Johnson & Johnson Health Care Systems Inc., Eli Lilly and Company,Moderna, Novartis, ParatusRx, Pfizer, Relypsa, Salamandra, Synthetic Biologics,Teva Pharmaceuticals USA Inc.and Theravance Biopharma Inc.

CardioNerdsHeart Failure Success Series PageCardioNerds Episode PageCardioNerds AcademyCardionerds Healy Honor Roll

CardioNerds Journal ClubSubscribe to The Heartbeat Newsletter!Check out CardioNerds SWAG!Become a CardioNerds Patron!

This CardioNerdsHeart Failure Success Series was created in memory of Dr. David Taylor. We thank our partners at the Heart Failure Society of Americawhich is a multidisciplinary organization working to improve and expand heart failure care through collaboration, education, research, innovation, and advocacy. Its members include physicians, scientists, nurses, nurse practitioners, and pharmacists. Learn more athfsa.org.

<a href="https://www.cardionerds.